Floatz logo

277 assets in Small Cell Lung Carcinoma

Therapeutic assets addressing Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bomedemstat
Small Cell Lung Carcinoma
University of WashingtonP1/2CC (47)
cp-383
Small Cell Lung Carcinoma
Tasca TherapeuticsP1/2CC (47)
dji136
Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1/2CC (47)
Fluoromisonidazole
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P2CC (47)
I-Dxd
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Ifebemtinib
Small Cell Lung Carcinoma
InxMed (Shanghai) Co., Ltd.P1/2CC (47)
Immunoglobulin G4-Kappa, Anti-[Homo Sapiens Btn1A1 (Butyrophilin Subfamily 1 Member A1)], Humanized Monoclonal Antibody
Small Cell Lung Carcinoma
STCube, Inc.P1/2CC (47)
Olvi-Vec
Small Cell Lung Carcinoma
Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.P1/2CC (47)
Osimertinib
Small Cell Lung Carcinoma
Misty ShieldsP1/2CC (47)
Quaratusugene Ozeplasmid
Small Cell Lung Carcinoma
Genprex, Inc.P1/2CC (47)
Fludarabine
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (46)
Neoantigen Dna Vaccine
Small Cell Lung Carcinoma
Washington University School of MedicineP2CC (46)
[203Pb]Pb-MP0712
Small Cell Lung Carcinoma
Molecular Partners AGP1/2CC (45)
[212pb]pb-mp0712
Small Cell Lung Carcinoma
Molecular Partners AGP1/2CC (45)
225ac-sso110
Small Cell Lung Carcinoma
Ariceum Therapeutics GmbHP1/2CC (45)
23me-00610
Small Cell Lung Carcinoma
23andMe, Inc.P1/2CC (45)
CD56 CAR-NK cells
Small Cell Lung Carcinoma
Beijing BiotechP1/2CC (45)
Cirtuvivint
Small Cell Lung Carcinoma
Washington University School of MedicineP1/2CC (45)
Eb-Dart-Nk01
Small Cell Lung Carcinoma
Beijing BiotechP1/2CC (45)
Favezelimab
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
ide161
Small Cell Lung Carcinoma
IDEAYA BiosciencesP1/2CC (45)
ide849
Small Cell Lung Carcinoma
IDEAYA BiosciencesP1/2CC (45)
Immunoglobulin G1, Anti-(Human Cytotoxic T-Lymphocyte-Associated Antigen 4) (Human-Mus Musculus Monoclonal M3 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal M3 .Kappa.-Chain, Dimer
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cdh6(Cadherin 6, K-Cadherin (Foetal Kidney), Cadherin 6 Type 2)], Humanized Monoclonal Antibody Conjugated To Deruxtecan, Comprising A Linker And A Camptothecin Derivative
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Small Cell Lung Carcinoma
Phanes TherapeuticsP1/2CC (45)
Jab-8263
Small Cell Lung Carcinoma
Jacobio Pharmaceuticals Co., Ltd.P1/2CC (45)
jk08
Small Cell Lung Carcinoma
Salubris Biotherapeutics IncP1/2CC (45)
Mrt-2359
Small Cell Lung Carcinoma
Monte Rosa Therapeutics, IncP1/2CC (45)
Nivatrotamab
Small Cell Lung Carcinoma
Y-mAbs TherapeuticsP1/2CC (45)
Retifanlimab
Small Cell Lung Carcinoma
Ariceum Therapeutics GmbHP1/2CC (45)
Spartalizumab
Small Cell Lung Carcinoma
SOLTI Breast Cancer Research GroupP2CC (45)
Tub-030
Small Cell Lung Carcinoma
Tubulis GmbHP1/2CC (45)
xnw5004
Small Cell Lung Carcinoma
Evopoint Biosciences Inc.P1/2CC (45)
Gamma4 Heavy Chain Homo Sapiens (1-446) [Vh (Homo Sapiens Ighv4-39*01 (96.0%) -(Ighd) -Ighj3*02 (100%), Cdr-Imgt [10.7.12] (26-35.53-59.98-109)) (1-120)-Homo Sapiens Ighg4*01, Ng4M(A) Ch2 L92, G4V5 H P10, G4V4 Ch2 A1.3, A1.2 (Ch1 (121-218), Hinge 1-12 S10>P (228) (219-230), Ch2 F1.3>A (234), L1.2>A (235), L92 (309) (231-340), Ch3 (341-445), Chs K2>Del (446)) (121-446)], (134-215')-Disulfide With Kappa Light Chain Homo Sapiens (1'-215') [V-Kappa (Homo Sapiens Igkv1-33*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt[6.3.10] (27'-32'.50'-52'.89'-98')) (1'-108') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (154'), V101 (192') (109'-215')], Dimer (226-226'':229-229'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho)-K1Sv Cell Line Lacking The Glutamine Synthetase Gene (Gs-Ko), Glycoform Alfa
Small Cell Lung Carcinoma
Innovent Biologics (Suzhou) Co. Ltd.P1CC (44)
MDM2 INHIBITOR AMG-232
Small Cell Lung Carcinoma
Kartos Therapeutics, Inc.P2CC (44)
Opnurasib
Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1CC (44)
rp12146
Small Cell Lung Carcinoma
Rhizen Pharmaceuticals SAP1CC (44)
[212pb]vmt-alpha-net
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (43)
225ac-abd147
Small Cell Lung Carcinoma
Abdera Therapeutics Inc.P1CC (43)
Alps12
Small Cell Lung Carcinoma
Chugai PharmaceuticalP1CC (43)
Anlotinib Hydrochloride Capsules
Small Cell Lung Carcinoma
Jinming YuP1CC (43)
ava6103
Small Cell Lung Carcinoma
Avacta Life Sciences LtdP1CC (43)
Cabozantinib
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (43)
cs231295
Small Cell Lung Carcinoma
Chipscreen Biosciences, Ltd.P1CC (43)
Egfr/B7H3 Car-T
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (43)
Elimusertib
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (43)
EMPM
Small Cell Lung Carcinoma
City of Hope Medical CenterP1CC (43)
Ezabenlimab
Small Cell Lung Carcinoma
Boehringer IngelheimP1CC (43)
gc511b car-t cell
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1CC (43)
Humanized Immunoglobulin G1-Kappa Anti-(Human Cd8) Fused At The C-Terminus Of One Heavy Chain, Via Peptide Linker <Sup>449</Sup> Sggggsggggsggggs<Sup>464</Sup>, To A Variant Of Human Interleukin-2, Glycoform Alfa
Small Cell Lung Carcinoma
AmgenP1CC (43)
Showing 151 to 200 of 277 assets
PreviousPage 4 of 6Next